We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CellOPTIQ® High Content Assay Confirmed as Leader in Assessing Cardiotoxicity

Product News   Sep 28, 2018

 
CellOPTIQ® High Content Assay Confirmed as Leader in Assessing Cardiotoxicity
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

New Recommendations for Assessing the Cardiac Safety of New Medicines

Product News

Metrion Biosciences has contributed to two new papers that focus on the application of improved cardiac safety testing protocols and recommendations for best practice for the drug discovery industry.

READ MORE

Horizon Discovery Expands Cell-based CRISPR Screening Services

Product News

Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.

READ MORE

Success in Next Phase of Open Source Malaria Initiative

Product News

Optibrium™ and Intellegens™ have successfully completed phase 2 of a global challenge aimed at developing and testing novel antimalarial compounds.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE